Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study

BACKGROUND: The interaction between hepatitis B virus (HBV) load and anti-programmed cell death (PD)-1 in combination with (+) antiangiogenic therapy remains controversial, especially for hepatocellular carcinoma (HCC) patients. This study sought to explore the effects of HBV load and antiviral ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Guosheng, Li, Rong, Li, Qi, Hu, Xiaoyun, Ruan, Jian, Fan, Wenzhe, Wang, Junjie, Huang, Wei, Zang, Mengya, Chen, Jinzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506751/
https://www.ncbi.nlm.nih.gov/pubmed/34733964
http://dx.doi.org/10.21037/atm-21-3020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506751/
https://www.ncbi.nlm.nih.gov/pubmed/34733964
http://dx.doi.org/10.21037/atm-21-3020

Ejemplares similares